Similar Posts
Want to Pay Higher Prices? Try a For-Profit Hospital!
ByadminIf she had been eligible for Medicare, the hospital would have charged the government $10,000 for the services it provided to her, with Medicare picking up most of the tab. But lacking insurance, she was billed directly from the hospital, and not for a mere $10,000. The total charge: $120,000! That 1200% markup is extreme….
Could a Zika Epidemic Be the Key to a Trump Victory?
ByadminPlatforms and popularity ratings; policies and debate performances; PAC funding and get-out-the-vote efforts – so many factors can make the difference in a close election. But uncontrollable world events can tip elections too. In fact, Donald Trump’s election chances may depend on something as seemingly random as a global epidemic. Epidemics of contagious disease are…
Are Medicare Prescription Benefits Too Stingy?
ByadminThe bill she received in the mail revealed a staggering figure — $9,225 for one infusion of Avastin, a chemotherapy drug. And she would need many more such infusions. Fortunately, the dollar amount is what medical experts call a “charge,” which in normal marketplaces refers to the amount a provider expects for the good or…
Charging Copays and Deductibles During a Pandemic Is Foolish—and Deadly (Newsweek)
BypeterIn areas of the country hardest hit by COVID-19, clinicians are already being forced to make tragic rationing decisions: about who to admit to the hospital, who to transfer to the ICU and who to place on scarce ventilators. These decisions feel out of character with our national identity. We normally think of ourselves as…
The Life-Expectancy Gap in One Depressing Picture
ByadminHere, from the Financial Times, is a picture showing that the lower your income, the less increase you’ve gotten in life-expectancy the last four decades: Income inequality is one of the largest human problems of this century.
The Cost of New Cancer Drugs (In One Picture)
Byadmin“Specialty drugs” – that’s what they’re called. Not the pills of old, these pharmaceuticals are often given intravenously or through injection. Often more biologic in their synthesis than chemical, they are expensive to produce and often target narrow disease processes, meaning the number of patients likely to benefit from them is much much smaller than,…
